A detailed history of Mairs & Power Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mairs & Power Inc holds 103,202 shares of PFE stock, worth $2.72 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
103,202
Previous 111,735 7.64%
Holding current value
$2.72 Million
Previous $3.13 Million 4.48%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $236,364 - $267,850
-8,533 Reduced 7.64%
103,202 $2.99 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $597,525 - $700,188
-23,655 Reduced 17.47%
111,735 $3.13 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.02 Million - $1.18 Million
-39,586 Reduced 22.62%
135,390 $3.76 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $2.16 Million - $2.8 Million
-82,576 Reduced 32.06%
174,976 $5.04 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $2.17 Million - $2.54 Million
-67,630 Reduced 20.8%
257,552 $8.54 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $1.65 Million - $1.91 Million
-45,648 Reduced 12.31%
325,182 $11.9 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $2.84 Million - $3.69 Million
-71,985 Reduced 16.26%
370,830 $15.1 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $1.18 Million - $1.54 Million
-28,278 Reduced 6.0%
442,815 $22.7 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.51 Million - $1.84 Million
-34,395 Reduced 6.8%
471,093 $20.6 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $4.41 Million - $5.23 Million
-94,764 Reduced 15.79%
505,488 $26.5 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $6.91 Million - $8.56 Million
-151,046 Reduced 20.1%
600,252 $31.1 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $36.5 Million - $54.2 Million
-884,335 Reduced 54.07%
751,298 $44.4 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $12.7 Million - $16.3 Million
-324,048 Reduced 16.54%
1,635,633 $70.3 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $1.82 Million - $2.06 Million
-50,736 Reduced 2.52%
1,959,681 $76.7 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $2.05 Million - $2.31 Million
-61,137 Reduced 2.95%
2,010,417 $72.8 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $6.6 Million - $8.39 Million
-197,088 Reduced 8.69%
2,071,554 $76.3 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $7.98 Million - $9.36 Million
-251,279 Reduced 9.97%
2,268,642 $83.3 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $7.04 Million - $8.54 Million
-233,610 Reduced 8.48%
2,519,921 $82.4 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $1.67 Million - $2.39 Million
-61,883 Reduced 2.2%
2,753,531 $89.9 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $40,425 - $45,878
-1,228 Reduced 0.04%
2,815,414 $110 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $14,523 - $18,832
447 Added 0.02%
2,816,642 $101 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $418,428 - $469,798
-11,315 Reduced 0.4%
2,816,195 $122 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $2.7 Million - $2.97 Million
-71,998 Reduced 2.48%
2,827,510 $120 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $22.1 Million - $25.2 Million
-573,950 Reduced 16.52%
2,899,508 $127 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $17.2 Million - $20.8 Million
-498,270 Reduced 12.55%
3,473,458 $153 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $8.42 Million - $8.98 Million
-255,342 Reduced 6.04%
3,971,728 $144 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $15.6 Million - $18.1 Million
-490,258 Reduced 10.39%
4,227,070 $150 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $1.64 Million - $1.74 Million
-49,443 Reduced 1.04%
4,717,328 $171 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $148 Million - $163 Million
4,766,771
4,766,771 $170 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Mairs & Power Inc Portfolio

Follow Mairs & Power Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.